Katherine Ruffner

Katherine Ruffner

No open positions remaining
Health Technology
Consumer Services

Profile

Katherine L.
Ruffner
worked as a Senior Director of Clinical Development at Seagen Inc. She was the Vice President of Clinical Development at CTI BioPharma Corp from 2008 to 2019.
Prior to that, she was an Assistant Professor at Vanderbilt University from 2002 to 2007.
She also worked as the Vice President of Clinical Development at ALX Oncology Holdings, Inc. from 2020 to 2021 and as the Chief Medical Officer at Cardiff Oncology, Inc. in 2021 to 2022.
Ruffner received her undergraduate degree from Duke University and her graduate degree from the University of Tennessee.

Former positions of Katherine Ruffner

CompaniesPositionEnd
CARDIFF ONCOLOGY, INC. Chief Tech/Sci/R&D Officer 2022-04-21
ALX ONCOLOGY HOLDINGS INC. Corporate Officer/Principal 2021-04-30
CTI BIOPHARMA CORP. Chief Tech/Sci/R&D Officer 2019-01-31
Corporate Officer/Principal 2006-12-31
SEAGEN INC. Chief Tech/Sci/R&D Officer -
See the detail of Katherine Ruffner's experience

Training of Katherine Ruffner

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

81

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Consumer Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Katherine Ruffner